Blockade of PKCε activation attenuates phorbol ester-induced increase of α-secretase-derived secreted form of amyloid precursor protein

被引:51
作者
Yeon, SW [1 ]
Jung, MW
Ha, MJ
Kim, SU
Huh, K
Savage, MJ
Masliah, E
Mook-Jung, I
机构
[1] Ajou Univ, Sch Med, Brain Dis Res Ctr, Suwon 442721, South Korea
[2] Ajou Univ, Sch Med, Inst Med Sci, Suwon 442721, South Korea
[3] Ajou Univ, Sch Med, Dept Neurol, Suwon 442721, South Korea
[4] Cephalon Inc, W Chester, PA 19380 USA
[5] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA
关键词
Alzheimer's disease; PKC epsilon; APP; beta-amyloid; sAPP; RACK;
D O I
10.1006/bbrc.2000.4181
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The role of PKC epsilon in amyloid precursor protein (APP) processing was investigated using APP-overexpressing B103 cells. As reported previously, a PKC activator, phorbol-12,13-dibutyrate (PDBu), enhanced secretion of APP alpha, and this effect was blocked by a PKC inhibitor, GF109203X in this system. Selective inhibition of PKC epsilon by overexpressing the PKC epsilon V1 region, which binds specifically to the receptor for activated C-kinase (RACK), blocked PDBu-induced enhancement of APP alpha secretion as well as PDBu-induced decrease in beta -secretase-derived APP C-terminal fragment production. On the other hand, the level of PKC epsilon, but not that of PKC alpha or PKC gamma, was substantially lower in the brains of Alzheimer's disease patients compared to age-matched controls. These results add to a growing body of evidence that PKC epsilon plays an important role in modulating APP processing, and suggest that reduced PKC epsilon activity may contribute to the development of Alzheimer's disease. (C) 2001 Academic Press.
引用
收藏
页码:782 / 787
页数:6
相关论文
共 32 条
[11]   Regulation of amyloid precursor protein (APP) secretion by protein kinase Cα in human ntera 2 neurons (NT2N) [J].
Jolly-Tornetta, C ;
Wolf, BA .
BIOCHEMISTRY, 2000, 39 (25) :7428-7435
[12]   CONVENTIONAL PROTEIN-KINASE-C (PKC)-ALPHA AND NOVEL PKC-EPSILON, BUT NOT PKC-DELTA, INCREASE THE SECRETION OF AN N-TERMINAL FRAGMENT OF ALZHEIMERS-DISEASE AMYLOID PRECURSOR PROTEIN FROM PKC CDNA TRANSFECTED 3Y1 FIBROBLASTS [J].
KINOUCHI, T ;
SORIMACHI, H ;
MARUYAMA, K ;
MIZUNO, K ;
OHNO, S ;
ISHIURA, S ;
SUZUKI, K .
FEBS LETTERS, 1995, 364 (02) :203-206
[13]  
LeBlanc AC, 1998, J NEUROSCI, V18, P2907
[14]  
LO ACY, 1994, J BIOL CHEM, V269, P30966
[15]  
Matsushima H, 1996, J NEUROCHEM, V67, P317
[16]   BETA-AMYLOID PRECURSOR PROTEIN METABOLITES AND LOSS OF NEURONAL CA2+ HOMEOSTASIS IN ALZHEIMERS-DISEASE [J].
MATTSON, MP ;
BARGER, SW ;
CHENG, B ;
LIEBERBURG, I ;
SMITHSWINTOSKY, VL ;
RYDEL, RE .
TRENDS IN NEUROSCIENCES, 1993, 16 (10) :409-414
[17]  
McMahon T, 2000, MOL PHARMACOL, V57, P53
[18]   Regulation of amyloid precursor protein cleavage [J].
Mills, J ;
Reiner, PB .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (02) :443-460
[19]   BETA-AMYLOID PRECURSOR PROTEIN OF ALZHEIMERS-DISEASE IN CULTURED BOVINE OLIGODENDROCYTES [J].
MIZUGUCHI, M ;
IKEDA, K ;
KIM, SU .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 32 (01) :34-42
[20]   Activity of α-secretase as the common final effector of protein kinase C-dependent and -independent modulation of amyloid precursor protein metabolism [J].
Racchi, M ;
Solano, DC ;
Sironi, M ;
Govoni, S .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) :2464-2470